Novartis is a Fair360 Top 50 Hall of Fame company.
Novartis and the Novartis US Foundation announced the expansion of their commitment to the Beacon of Hope initiative.
Beacon of Hope is a 10-year commitment to co-create programs that address health and education inequities and foster greater equity, inclusion and trust across the research and development ecosystem.
“Our relentless commitment to the success of Beacon of Hope led us to undertake a comprehensive assessment of where we have made important progress and where we still have gaps to fulfilling the mission of the program,” said Linda Armstrong, US Novartis Foundation President and Head of Novartis US Corporate Responsibility. “We actively sought out collaborations with organizations that both possess the expertise necessary to bridge these gaps — particularly on the technology front — and that share our unwavering mission to tackle the fundamental factors that contribute to health and education disparities.”
